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Abstract
The article by Daniels and colleagues on expanding the scope of health technology assessment (HTA) to embrace 
ethical analysis has received endorsement and criticism from commentators in this journal. Referring to this debate, 
we examine in this article the extent and locus of ethical analysis in HTA processes. An expansion/no-expansion 
framing of HTA is, in our view, not very fruitful. We argue that meaningfulness and relevance to the needs of the 
population are what should determine the extent of ethics in HTA. Once ‘relevance’ is the guiding principle, engaging 
in ethical analysis becomes inevitable as values are all over the place in HTA, also in how assessors frame research 
questions. We also challenge dividing the locus of ethical analysis into assessment and appraisal as this would detach 
HTA from its purpose, ie, supporting legitimate decision-making. Ethical analysis should therefore be considered 
integral to the HTA process. 
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An editorial by Daniels and colleagues entitled, “Expanded HTA: Enhancing Fairness and Legitimacy,”1 has set forth a debate accompanied by a number 
of successive commentaries in this journal.2-6 The debate 
addresses a core issue regarding the role of health technology 
assessment (HTA) for legitimising decisions on health 
interventions. Central to the debate is a call to broaden the 
scope of HTA to embrace social and ethical issues such as 
equity and distributional impacts. The discussion also touches 
a longstanding, still unfinished, debate on the locus of such 
analyses within HTA processes: whether ethical appraisal of a 
health intervention is – in terms of content – separate from its 
technical assessment or interwoven with it. In this article we 
contribute to this debate with a view to examining the extent 
and locus of ethical inquiry in HTA.
To Expand or not to Expand? 
As we see it, “expansion” involves a problematic framing for 
the scope of HTA. Expansion entails surpassing a boundary. 
Likewise, a ‘no-extension’ argument, as Culyer makes,2 
involves the underlying assumption that we are deviating from 
a pre-existing assessment framework already demarcated 
by a specific discipline (medical science, epidemiology, 
health economics, or otherwise) and generally agreed upon 
within the HTA community. This view inevitably demands 
identifying where the boundary of expansion lies. For 
instance, in disagreeing with the suggestion of Daniels and 
colleagues to consider “matters other than safety and cost-
effectiveness” in HTA, Culyer draws a line of ‘unnecessarily’ 
expanding HTA. 
We reject a by-exclusion framing of HTA arisen from such 
an expansion/no-expansion argument, be it per domain or 
discipline, by calculation or deliberation, academic or non-
academic, or otherwise. In our opinion, ‘meaningfulness 
and relevance’ to the needs of the population must be the 
prime criteria for determining the extent of HTA and for 
‘sufficiency’5 of analyses. As a tool to inform decision-
making regarding health interventions, HTA must remain 
user-centred in the same fashion that airlines services must 
be tailored to the needs of passengers or health services to 
those of patients. The extent of an assessment (its evaluative 
scope) should, in turn, be fit for the purpose of ‘legitimising 
decisions,’4 from both a practical and an epistemological point 
of view. A fit-for-purpose HTA is neither reductionistic nor 
unnecessarily exhaustive in terms of types of disciplinary 
perspectives, stakeholders involved, and the application of 
algorithmic calculations or deliberative processes. In a similar 
vein, an extensive elaboration of general ethical principles may 
in certain circumstances be rendered unnecessary, as equally 
may sophisticated modelling techniques. Notwithstanding, 
the health intervention in question should determine the 
content of HTA.2 
To Expand or to Integrate?
Once ‘relevance’ is the guiding principle, it must be justified 
with adequate reasoning. Engaging in ethical analysis then 
becomes inevitable, thereby, integral to HTA processes. For 
example, HTA influences how pooled, but scarce resources 
eventually address the needs of the population; and the 
selection and/or exclusion of issues to address in HTA reports 
has normative bearings.7 If no significant ethical issue is 
conceivable for the health intervention at hand, an elaborate 
ethical analysis may not be necessary (eg, in a case of a new 
me-too anti-cholesterol drug). Note: this is an if-clause. To 
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ascertain the conditions of this ‘if,’ the assessor will inevitably 
have to examine budget, distributional, and financial 
protection impact. Nevertheless, several surveys and reviews 
show that HTA reports seldom explicitly address ethical 
issues.1,8-12 Some commentators in this journal reiterate this 
and endorse the integration of ethical analysis, including 
equity and fairness considerations into HTA. Culyer, however, 
argues that not all HTA reports need ethics; and that unveiling 
all specific ethical judgements would, in fact in itself, be 
unethical.2 We agree with Culyer and others who assert that 
not all ethical aspects of all health interventions have to be 
addressed for every HTA.13 Ethical analysis is, again, better 
conceived in accordance to the ‘relevance’ argument. This 
would also prevent inconsistency, eg, claiming that the job 
of assessors is to “populate the HTA process with ideas and 
evidence,” while regarding the equity and distributional 
impacts of the health intervention as “excessive.”2 
Moreover, the fact that ethics is already embedded in HTA 
processes – notably in terms of minimizing opportunity 
costs – does not guarantee adequate ‘ethical reasoning’ 
or ‘social learning’ (eg, regarding societal values beyond 
health gains that cannot be easily quantified).3,10 Nor does 
this preclude one from examining all the value judgements 
underlying calculative assessments, including the relevance 
of cut-off points, outcome measures, time frame, indirect 
medical costs or costs outside the health care system, cost-
effectiveness thresholds, and trade-offs between advantages 
and disadvantages of different measurement methodologies, 
to name but a few.7,14 These choices and assumptions are often 
not made explicit in an HTA report. They, however, could 
nontrivially influence patterns of utilization and eventually 
resource (re-)distribution. The devil would then be in these 
details, challenging Culyer’s idea of the intrinsic innocence 
of the tool: “Frequently what is wrong is not the tool but its 
users or the environment….” Are not you then engaging in 
an ethical analysis with regard to justifying the scope and 
tool of the assessment? This is indeed separate from the fact 
that equity considerations in resource distribution are partly 
captured by “a correctly-perceived idea of cost-effectiveness 
analysis in health care.”2 
Division of Labour Between the Two Cultures: Can You 
Keep Your Hands Off?
Ambivalence exists about where ethical issues should be 
handled: is it the task of decision-makers or do we want most 
of them integrated in HTA analyses? The same commentator, 
who argues that HTA frameworks should allow decision-
makers to consider “all relevant, quantitatively and ethically 
significant issues,” also asserts that “[i]t is not necessary – 
indeed it is unethical – to prescribe all the specific ethical 
judgments that may have to be made. That is not the job of 
analysts but of decision-makers and their advisers.”2 In saying 
that HTA should not become prescriptive, Culyer notes 
that (a) scientific evidence should not be the ‘sole basis’ for 
making decisions and (b) responsibility and discretion rest on 
the decision-maker rather than the assessor. We agree and re-
emphasise these points. However, we strongly doubt whether 
aiming at minimal ‘meddling’ with the job of decision-makers 
renders the assessments relevant or well-reasoned. The 
calculative assessments may either lose practical relevance or 
they may be regarded by the decision-maker and the public 
as prescriptive, not because their evaluative scope is adequate, 
but since they carry the connotation of being impartial or 
objective.15 Acknowledging and explicitly addressing ethical 
issues along with technical assessment provide the decision-
maker with a more balanced/nuanced input for deciding on 
a certain course of action. Rather than prescriptively limiting 
the choices, such an ethical analysis clarifies existing choices 
made and the consequences thereof, even if it does not open 
up previously-neglected choices. It also feeds rather than 
discourages evidence-informed deliberative processes.16 
It is widely acknowledged that the division between assessors 
and decision-makers, between fact (assessment) and 
value (appraisal), and between technocratic and political 
legitimisation has made HTA processes fall short to properly 
address ethical issues.3,4,10,12,16,17 Such division could be 
incongruent with the relevance argument. To those who 
promote this division, it should not matter if the conclusions 
of the assessments – having been pushed in an algorithmic 
direction2,18 – are ignored. It would, then, be defeating the 
purpose to expect legitimisation and transparency of decisions 
by means of HTA, while at the same time believing that 
assessors are only there to deliver evidence at the door. This 
leaves a lot of room for a decision-maker’s ad hoc personal 
feelings/expedience/interest, raising the question of why HTA 
is needed in the first place. Making decisions to optimize 
value10 is indeed the authority and responsibility of decision-
makers, its ‘relevance and reasonableness’ however, relies on 
the work of assessors. The choice is, as Daniels and van der 
Wilt put it, “between HTA remaining a source of incomplete 
advice…, thus risking an important kind of marginalization, 
and HTA…to provide as complete an assessment of a 
technology as possible” (p. 12).10 You may have to choose: 
keeping your hands off or having an impact, because if HTA 
wants to have an impact on decisions, its hands may very well 
become openly involved. 
Conclusion
We argue that the relevance to the decision at hand is what 
should determine the content of HTA. Ethical underpinnings 
of cost-effectiveness analyses do not, in themselves, assure 
adequate ethical reasonableness in an HTA. Ethical analysis 
is integral to the whole HTA process as it contributes to how 
HTA is defined, interpreted, and acted upon. It includes equity 
and distributional considerations but also all value judgments 
inherently involved in assessments. To examine the extent and 
the role of ethical analysis in HTA, we may need to make up 
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